This profile is maintained by the Sesamers data desk. Claim it to edit details, post jobs and answer interviews.
-
Total raised
-
Valuation
11
Employees
2016
Founded
Latest round
Series C - October 15, 2026
Series C - €276,100,000
October 15, 2026
Bain Capital Life Sciences - Verified by the Sesamers desk Forbion - Verified by the Sesamers desk Novo Holdings - Verified by the Sesamers desk British Business Bank - Verified by the Sesamers desk Google Ventures - Verified by the Sesamers desk Janus Henderson Investors - Verified by the Sesamers desk Jefferson Life Sciences - Verified by the Sesamers desk Northpond Ventures - Verified by the Sesamers desk Oxford Science Enterprises - Verified by the Sesamers desk Sanofi Ventures - Verified by the Sesamers desk SV Health Investors - Verified by the Sesamers desk Syncona - Verified by the Sesamers desk
Janus Henderson Investors, SV Health Investors, Jefferson Life Sciences, Syncona, Oxford Science Enterprises, GV, Northpond Ventures, Sanofi Ventures, British Business Bank, University of Oxford
✓ verified by our desk
Open roles
OMass Therapeutics is not hiring through Sesamers right now.
Work here? Claim the profile and post roles.
Claim your profile